Citation only
via OpenAlex
Mitochondrial Disorders in Alzheimer’s Disease
В. С. Сухоруков, Natalia M. Mudzhiri, Anastasia S. Voronkova, Т. И. Баранич, В. В. Глинкина, С. Н. Иллариошкин
Biochemistry (Moscow) · 2021 · ▲ 30 citations
Abstract
Alzheimer's disease is the most common age-related neurodegenerative disease. Understanding of its etiology and pathogenesis is constantly expanding. Thus, the increasing attention of researchers is directed to the study of the role of mitochondrial disorders. In addition, in recent years, the concept of Alzheimer's disease as a stress-induced disease has begun to form more and more actively. The stress-induced damage to the neuronal system can trigger a vicious circle of pathological processes, among which mitochondrial dysfunctions have a significant place, since mitochondria represent a substantial component in the anti-stress activity of the cell. The study of mitochondrial disorders in Alzheimer's disease is relevant for at least two reasons: first, as important pathogenetic component in this disease; second, due to vital role of mitochondria in formation of the body resistance to various conditions, including stressful ones, throughout the life. This literature review analyzes the results of a number of recent studies assessing potential significance of the mitochondrial disorders in Alzheimer's disease. The probable mechanisms of mitochondrial disorders associated with the development of this disease are considered: bioenergetic dysfunctions, changes in mitochondrial DNA (including assessment of the significance of its haplogroup features), disorders in the dynamics of these organelles, oxidative damage to calcium channels, damage to MAM complexes (membranes associated with mitochondria; mitochondria-associated membranes), disruptions of the mitochondrial quality control system, mitochondrial permeability, etc. The issues of the "primary" or "secondary" mitochondrial damage in Alzheimer's disease are discussed. Potentials for the development of new methods for diagnosis and therapy of mitochondrial disorders in Alzheimer's disease are considered.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1134/s0006297921060055
- Canonical
- link ↗
- Fetched
- 2026-06-06 MST
Cite this
APA
Сухоруков, �.�., Mudzhiri, N.M., Voronkova, A.S., Баранич, �.�., Глинкина, �.�., & Иллариошкин, �.�. (2021). Mitochondrial Disorders in Alzheimer’s Disease. <em>Biochemistry (Moscow)</em>. https://doi.org/10.1134/s0006297921060055
Vancouver
Сухоруков ��, Mudzhiri NM, Voronkova AS, Баранич ��, Глинкина ��, Иллариошкин ��. Mitochondrial Disorders in Alzheimer’s Disease. Biochemistry (Moscow). 2021. doi:10.1134/s0006297921060055.
BibTeX
@article{2021Mitoch,
title = {Mitochondrial Disorders in Alzheimer’s Disease},
author = {В. С. Сухоруков and Natalia M. Mudzhiri and Anastasia S. Voronkova and Т. И. Баранич and В. В. Глинкина and С. Н. Иллариошкин},
journal = {Biochemistry (Moscow)},
year = {2021},
doi = {10.1134/s0006297921060055},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Laboratory Investigation 2000
Open access · OA
Mitochondrial DNA Damage as a Mechanism of Cell Loss in Alzheimer's Disease
Neurochemistry International 2004
Citation only
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012
Open access · OA
Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
Cells 2020
Open access · CC-BY
Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases
Journal of Neuroinflammation 2022
Open access · CC-BY
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
European Neuropsychopharmacology 2019
Citation only